Catalent Pharma Solutions broadened the scope of its OptiForm Solution Suite platform to provide an efficient and seamless path from late-stage discovery to phase I clinical trials. Designed to make it easier and faster for small and mid-sized innovators to develop better treatments, the new OptiForm Solution Suite service will now include more comprehensive candidate screening tools, Absorption, Distribution, Metabolism and Excretion (ADME) considerations and in silico Drug Metabolism and Ph...